Prior to joining SK Capital, Mr. Davenport was a Principal at Arsenal Capital Partners where he co-led Arsenal’s healthcare investing efforts and served on the firm’s Operating and Investment Committees. While at Arsenal, Mr. Davenport worked closely with Mr. Marden on then current portfolio companies Scientific Protein Laboratories, Priority Solutions and Innovative Medical Device Solutions. Mr. Davenport was also the Chairman of portfolio company Charter Brokerage. Before joining Arsenal, Mr. Davenport was a healthcare industry strategy consultant with Braun Consulting and was previously Director of Business Strategy and Development for CB Richard Ellis/Whittier Partners.
He currently serves on the Board of Directors of IBA Molecular, Bend Research, Inc. and IRIX Pharmaceuticals, Inc.
Mr. Davenport graduated magna cum laude with a B.A. in History from Amherst College and has an M.B.A. from the Tuck School of Business at Dartmouth College.